Trademark: 78274936
Word
GENEOPTIMIZER
Status
Registered
Status Code
800
Status Date
Tuesday, June 14, 2016
Serial Number
78274936
Registration Number
3111123
Registration Date
Tuesday, July 4, 2006
Mark Type
1000
Filing Date
Wednesday, July 16, 2003
Published for Opposition
Tuesday, April 11, 2006

Trademark Owner History

Classifications
9 [ Computer terminals; ] computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; [ computer operating programs; computer peripheral devices; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processing equipment, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; notebook computers; ] automatic machines for the synthesis of deoxyribonucleic acids; and robotic machines for laboratory purposes
5 [ Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones, and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for medical and laboratory equipment, institutional use, and domestic uses; vermicides for medical and laboratory equipment, institutional use, domestic use, and residential uses; fungicides for medical and laboratory equipment, institutional use, and domestic uses; biological and diagnostic materials and preparations for clinical and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof ]
1 [ Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological and diagnostic materials and preparations for research use, namely, proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds ]
42 Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software; computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering and machine engineering; consultation pertaining to pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; and quality control for others
GENE OPTIMIZER
Color is not claimed as a feature of the mark.

Trademark Events
Mar 10, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 10, 2023
Teas Change Of Correspondence Received
Mar 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 10, 2023
Teas Change Of Owner Address Received
Jun 14, 2016
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jun 14, 2016
Registered And Renewed (First Renewal - 10 Yrs)
Jun 14, 2016
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jun 13, 2016
Teas Section 8 & 9 Received
Mar 2, 2016
Automatic Update Of Assignment Of Ownership
Jul 4, 2015
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jul 23, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 23, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 10, 2012
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Aug 10, 2012
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jul 23, 2012
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Aug 10, 2012
Case Assigned To Post Registration Paralegal
Jul 23, 2012
Teas Section 8 & 15 Received
Jul 23, 2012
Teas Change Of Correspondence Received
Oct 21, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 21, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 2, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 2, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 1, 2011
Teas Change Of Correspondence Received
Sep 20, 2006
Automatic Update Of Assignment Of Ownership
Jul 4, 2006
Registered-Principal Register
Apr 11, 2006
Published For Opposition
Mar 22, 2006
Notice Of Publication
Feb 2, 2006
Law Office Publication Review Completed
Sep 23, 2005
Assigned To Lie
Sep 19, 2005
Approved For Pub - Principal Register
Sep 19, 2005
Examiners Amendment E-Mailed
Sep 19, 2005
Examiners Amendment -Written
Sep 14, 2005
Previous Allowance Count Withdrawn
Sep 12, 2005
Withdrawn From Pub - Og Review Query
Aug 23, 2005
Law Office Publication Review Completed
Aug 19, 2005
Assigned To Lie
Aug 15, 2005
Approved For Pub - Principal Register
Aug 15, 2005
Teas/Email Correspondence Entered
Aug 8, 2005
Correspondence Received In Law Office
Aug 8, 2005
Teas Response To Office Action Received
Jul 8, 2005
Priority Action E-Mailed
Jul 8, 2005
Priority Action Written
Jul 6, 2005
Previous Allowance Count Withdrawn
Jun 17, 2005
Withdrawn Before Publication
Sep 17, 2004
Assigned To Lie
Sep 7, 2004
Law Office Publication Review Completed
Sep 3, 2004
Assigned To Lie
Jun 3, 2004
Approved For Pub - Principal Register
May 5, 2004
Sec. 1(B) Claim Deleted
May 5, 2004
Correspondence Received In Law Office
May 5, 2004
Paper Received
Jan 6, 2004
Non-Final Action E-Mailed
Jan 5, 2004
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24